Zenaida Maddela, MD
Internal Medicine · Henderson, KYNPI 1487662011
Payments from drug & device makers
Across 30 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$104
- Amarin Pharma, Inc.$94
- AbbVie$71
- E.r. Squibb & Sons, L.L.C.$53
- Boehringer Ingelheim$33
- Otsuka America Pharmaceutical, Inc.$29
- plus $129 from 8 others
What the payments were for
- Food & beverage$515100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 7 | $104 |
| Amarin Pharma, Inc. | 6 | $94 |
| AbbVie | 1 | $71 |
| E.r. Squibb & Sons, L.L.C. | 4 | $53 |
| Boehringer Ingelheim | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Novo Nordisk | 1 | $23 |
| AstraZeneca | 1 | $20 |
| Innocoll Pharmaceuticals Limited | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| GSK | 1 | $13 |
| Biogen | 1 | $12 |
| Pfizer | 1 | $11 |
How this compares
$515 in reported general payments places this provider in the 50th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,126 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $1,100 |
| Losartan Potassium | 41 | $335 |
| Metoprolol Succinate | 22 | $251 |
| Fluticasone Propionate | 20 | $211 |
| Atorvastatin Calcium | 37 | $197 |
| Levothyroxine Sodium | 33 | $195 |
| Azithromycin | 24 | $127 |
| Omeprazole | 30 | $122 |
| Amlodipine Besylate | 44 | $112 |
| Amoxicillin | 52 | $109 |
| Doxycycline Hyclate | 14 | $90 |
| Clonidine Hcl | 16 | $77 |
| Montelukast Sodium | 16 | $71 |
| Furosemide | 15 | $66 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Henderson
- Mark AdamsLondon$15.4M
- Matthew WenkerErlanger$12.8M
- Jason ChesneyLouisville$6.3M
- Neil FarrisLexington$3M
- David JohnsonOwensboro$787K
- Hollis ClarkMurray$780K
- Fares KhaterWhitesburg$412K
- Christopher PhillipsPaducah$315K
- Cynthia Bowman-StroudPaducah$234K
- Bernard BuchananOwensboro$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.